TY - JOUR
T1 - Estimated incubation period distributions of mpox using cases from two international European festivals and outbreaks in a club in Berlin, May to June 2022
AU - McFarland, Sarah E.
AU - Marcus, Ulrich
AU - Hemmers, Lukas
AU - Miura, Fuminari
AU - Martínez, Jesús Iñigo
AU - Martínez, Fernando Martín
AU - Montalbán, Elisa Gil
AU - Chazelle, Emilie
AU - Mailles, Alexandra
AU - Silue, Yassoungo
AU - Hammami, Naïma
AU - Lecompte, Amaryl
AU - Ledent, Nicolas
AU - Berghe, Wim Vanden
AU - Liesenborghs, Laurens
AU - Van den Bossche, Dorien
AU - Cleary, Paul R.
AU - Wallinga, Jacco
AU - Robinson, Eve P.
AU - Johansen, Tone Bjordal
AU - Bormane, Antra
AU - Melillo, Tanya
AU - Seidl, Cornelia
AU - Coyer, Liza
AU - Boberg, Ronja
AU - Jurke, Annette
AU - Werber, Dirk
AU - Bartel, Alexander
N1 - Publisher Copyright:
© 2023 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
PY - 2023/7/6
Y1 - 2023/7/6
N2 - Background: Since May 2022, an mpox outbreak affecting primarily men who have sex with men (MSM) has occurred in numerous non-endemic countries worldwide. As MSM frequently reported multiple sexual encounters in this outbreak, reliably determining the time of infection is difficult; consequently, estimation of the incubation period is challenging. Aim: We aimed to provide valid and precise estimates of the incubation period distribution of mpox by using cases associated with early outbreak settings where infection likely occurred. Methods: Colleagues in European countries were invited to provide information on exposure intervals and date of symptom onset for mpox cases who attended a fetish festival in Antwerp, Belgium, a gay pride festival in Gran Canaria, Spain or a particular club in Berlin, Germany, where early mpox outbreaks occurred. Cases of these outbreaks were pooled; doubly censored models using the log-normal, Weibull and Gamma distributions were fitted to estimate the incubation period distribution. Results: We included data on 122 laboratory-confirmed cases from 10 European countries. Depending on the distribution used, the median incubation period ranged between 8 and 9 days, with 5th and 95th percentiles ranging from 2 to 3 and from 20 to 23 days, respectively. The shortest interval that included 50% of incubation periods spanned 8 days (4–11 days). Conclusion: Current public health management of close contacts should consider that in approximately 5% of cases, the incubation period exceeds the commonly used monitoring period of 21 days.
AB - Background: Since May 2022, an mpox outbreak affecting primarily men who have sex with men (MSM) has occurred in numerous non-endemic countries worldwide. As MSM frequently reported multiple sexual encounters in this outbreak, reliably determining the time of infection is difficult; consequently, estimation of the incubation period is challenging. Aim: We aimed to provide valid and precise estimates of the incubation period distribution of mpox by using cases associated with early outbreak settings where infection likely occurred. Methods: Colleagues in European countries were invited to provide information on exposure intervals and date of symptom onset for mpox cases who attended a fetish festival in Antwerp, Belgium, a gay pride festival in Gran Canaria, Spain or a particular club in Berlin, Germany, where early mpox outbreaks occurred. Cases of these outbreaks were pooled; doubly censored models using the log-normal, Weibull and Gamma distributions were fitted to estimate the incubation period distribution. Results: We included data on 122 laboratory-confirmed cases from 10 European countries. Depending on the distribution used, the median incubation period ranged between 8 and 9 days, with 5th and 95th percentiles ranging from 2 to 3 and from 20 to 23 days, respectively. The shortest interval that included 50% of incubation periods spanned 8 days (4–11 days). Conclusion: Current public health management of close contacts should consider that in approximately 5% of cases, the incubation period exceeds the commonly used monitoring period of 21 days.
UR - http://www.scopus.com/inward/record.url?scp=85164253216&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2023.28.27.2200806
DO - 10.2807/1560-7917.ES.2023.28.27.2200806
M3 - Article
C2 - 37410383
AN - SCOPUS:85164253216
SN - 1025-496X
VL - 28
JO - Eurosurveillance
JF - Eurosurveillance
IS - 27
ER -